Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Apellis Pharmaceuticals Inc (NQ: APLS ) 44.92 +0.73 (+1.65%) Streaming Delayed Price Updated: 12:01 PM EDT, May 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 859,899 Open 44.75 Bid (Size) 44.86 (4) Ask (Size) 44.92 (1) Prev. Close 44.19 Today's Range 44.49 - 47.23 52wk Range 19.83 - 94.75 Shares Outstanding 116,457,008 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Today 7:00 EDT From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA) April 26, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Performance YTD -26.69% -26.69% 1 Month -24.77% -24.77% 3 Month -31.91% -31.91% 6 Month -7.69% -7.69% 1 Year -45.83% -45.83% More News Read More Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results April 23, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Expert Ratings For Apellis Pharmaceuticals April 15, 2024 Via Benzinga If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,000 Today April 10, 2024 Via Benzinga The 5 Stocks Most Sold By Insiders This Year April 16, 2024 Via MarketBeat Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 04, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference April 01, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire $1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today March 29, 2024 Via Benzinga Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals March 27, 2024 Via Benzinga Peering Into Apellis Pharmaceuticals's Recent Short Interest March 15, 2024 Via Benzinga Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (18 Ratings) February 28, 2024 Via Benzinga Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor March 11, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 06, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Beam Therapeutics Bolts Higher on Gene Therapy Licensing Payments March 06, 2024 Via MarketBeat Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years February 22, 2024 Via Benzinga $1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today February 05, 2024 Via Benzinga ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday February 28, 2024 Via Benzinga Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Apellis Pharmaceuticals to Present at Upcoming Investor Conferences February 26, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results February 20, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know January 30, 2024 Via Benzinga Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 06, 2024 From Apellis Pharmaceuticals, Inc. Via GlobeNewswire Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday February 05, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
